RT Journal Article SR Electronic T1 Outbreak-associated Salmonella Baildon found in wastewater demonstrates how sewage monitoring can supplement traditional disease surveillance JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2024.07.03.24308516 DO 10.1101/2024.07.03.24308516 A1 M’ikanatha, Nkuchia M. A1 Goldblum, Zoe S. A1 Cesari, Nicholas A1 Nawrocki, Erin M. A1 Fu, Yezhi A1 Kovac, Jasna A1 Dudley, Edward G. YR 2024 UL http://medrxiv.org/content/early/2024/07/05/2024.07.03.24308516.abstract AB Non-typhoidal Salmonella is a common cause of gastroenteritis worldwide, but current non-typhoidal Salmonella surveillance is suboptimal. Here we evaluated the utility of wastewater monitoring to enhance surveillance for this foodborne pathogen. In June 2022, we tested composite raw sewage collected twice a week from two treatment plants in central Pennsylvania for non-typhoidal Salmonella and characterized isolates using whole genome sequencing. We recovered 43 Salmonella isolates from wastewater samples, differentiated by genomic analysis into seven serovars: 16 Panama (37.2%), 9 Senftenberg (20.9%), and 8 Baildon (18.6%), 3 or fewer for four other serovars. We assessed genetic relatedness and epidemiologic links between non-typhoidal Salmonella serovars from wastewater and isolates from patients with salmonellosis. All S. Baildon serovars from wastewater were genetically and epidemiologically associated with a known salmonellosis outbreak. S. Baildon from wastewater and 42 outbreak-related isolates in the national outbreak detection database had the same core genome multilocus sequence typing and code differed by no or one single polynucleotide polymorphisms. One of the 42 outbreak-related isolates was obtained from a patient residing in the wastewater sample collection catchment area, which serves approximately 17000 people. S. Baildon is a rare serovar (reported in <1% cases nationally over five years). Our study underscores the value of monitoring sewage from a defined population to supplement traditional surveillance methods for evidence of Salmonella infections and to determine the extent of outbreaks.Importance statement During the COVID-19 pandemic, surveillance for SARS-CoV-2 in wastewater was a powerful tool for assessing community burden days ahead of traditional reporting. Here, we show that domestic sewage monitoring is useful for surveillance for a foodborne pathogen. Salmonella enterica was detected in samples from two wastewater treatment plants in central Pennsylvania during June 2022. Using whole genome sequencing, we demonstrated that isolates of variant S. Baildon clustered with those from an outbreak that occurred in a similar time frame. Case reports were primarily from Pennsylvania, and one individual lived within the treatment center catchment area. This study provides support for the utility of domestic sewage surveillance in assisting public health agencies identify communities impacted by infectious diseases.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding was provided by the Centers for Disease Control and Prevention Epidemiology and Laboratory Capacity (ELC) for collaboration in National Antimicrobial Resistance Monitoring (CDC-RFA-CI10-101204PPHF13), U.S. Food and Drug Administration grant number 1U01FD006253-01 to PADOH for collaboration in the National Antimicrobial Resistance Monitoring System, and the US Food and Drug Administration (Grant No. 1U19FD007114-01) to E.G.D. E.M.N was funded by a USDA-NIFA Postdoctoral Fellowship 2021-67034-35120. E.G.D. was additionally supported by USDA National Institute of Food and Agriculture and Hatch Appropriations PEN4826, and J.K. was supported by PEN04853 and Multistate project 4666.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics Committee for the Centers for Disease Control and Prevention National Antimicrobial Resistance Monitoring System (CDC NARMS IRB) Ethics Pennsylvania Department of Health IRB accepted CDC NARMS IRB oversight I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesSequence short reads for all wastewater isolates were uploaded to the NCBI under BioProject PRJNA357723. Accession numbers are provided in Supplementary Tables 1 and 2 for isolates from sewage and clinical sources, respectively.